Skip to main content
logo
SCYNEXIS, Inc. (SCYX)
NASDAQ: SCYX · Real-Time Price · USD
4.480
+0.100 (2.28%)
At close: Jul 13, 2026, 4:00 PM EDT
4.540
+0.060 (1.34%)
After-hours: Jul 13, 2026, 4:10 PM EDT

SCYNEXIS Revenue

SCYNEXIS had revenue of $18.90M in the twelve months ending March 31, 2026, up 618.63% year-over-year. In the year 2025, SCYNEXIS had annual revenue of $41.20M with 449.95% growth.

Revenue (ttm)
$18.90M
Revenue Growth
+618.63%
P/S Ratio
2.19
Revenue / Employee
$1,130,222
Employees
18
Market Cap
44.49M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202541.20M33.71M449.95%
Dec 31, 20247.49M-272.79M-97.33%
Dec 31, 2023280.28M270.10M2,652.72%
Dec 31, 202210.18M-16.14M-61.32%
Dec 31, 202126.33M--
Dec 31, 2020---
Dec 31, 2019121.00K-136.00K-52.92%
Dec 31, 2018257.00K--
Dec 31, 2017257.00K--
Dec 31, 2016257.00K--
Dec 31, 2015257.00K-999.00K-79.54%
Dec 31, 20141.26M-15.60M-92.55%
Dec 31, 201316.86M20.00K0.12%
Dec 31, 201216.84M-9.62M-36.35%
Dec 31, 201126.45M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
InterCure84.76M
Aytu BioPharma56.60M
Zhengye Biotechnology Holding16.64M
China Pharma Holdings3.99M
TherapeuticsMD3.35M
China SXT Pharmaceuticals1.14M
BioXcel Therapeutics680.00K
Optimi Health166.11K
Revenue Rankings

SCYX News

More News